Anti-maskers hurl abuse, threats after Tennessee school board reinstates mandate


Authors: By Yaron Steinbuch Wild video captured a group of irate people in Tennessee hurling threats at health care professionals and school board members after a mask mandate was reinstated — with one man threatening, “We know who you are! You can leave freely, but we will find you!” The chaos erupted Tuesday night in Franklin, […]

Fauci Confirms “Likely, Inevitable” Everyone Will Need COVID Vaccine Booster Shot


Authors: BY TYLER DURDEN Within the space of a few days, the narrative has shifted from “if” booster shots are even necessary, to “only for immunocompromised“, to “only for those who got vaccinations early on, due to fading efficacy“, and now today, His Omniscience Anthony Fauci told ‘CBS This Morning’ that while it is imminent that immune compromised people will […]

Israel, 80% Vaccinated, Suffers Another Covid-19 Surge


Country delivers more booster shots, restores mask and quarantine mandates as Delta variant drives up hospitalizations Authors: Dov Lieber TEL AVIV—After becoming one of the first countries to open up thanks to a widespread Covid-19 vaccination campaign, Israel is again on guard, this time against the spread of the Delta variant of the coronavirus. Mask mandates are […]

Biden’s big COVID challenge: Fading vaccines may demand boosters


Authors: Caitlin Owens, Sam Bake The Biden administration is intensely scrutinizing coronavirus vaccines’ effectiveness over time, facing the daunting task of timing booster shots right while still convincing the unvaccinated that getting the jab is worthwhile. The bottom line: The vaccines still work incredibly well at protecting against severe disease and death, meaning the benefits of getting […]


Contributors BC, CW, and YeW had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. CW and BC decided to publish the paper. BC, CW, YeW, PWH, TJ, and FGH provided input on the trial design. BC, CW, […]

Study: Remdesivir Does Not Reduce COVID Mortality


Authors: By Ralph Ellis October 19, 2020 — A large study sponsored by the World Health Organization found that remdesivir doesn’t help hospitalized patients with COVID-19 survive and doesn’t even shorten the recovery time of those who do survive. These findings contradict smaller studies which found remdesivir, an antiviral drug, helped hospitalized coronavirus patients recover […]

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19


Authors: NIAID Office of Communications Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by […]

The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug


Authors: By Jon Cohen, Kai KupferschmidtOct. 28, 2020 , 7:05 PM October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a deal potentially worth more than $1 […]

Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery


Authors:  Beigel, et al. Remdesivir for the Treatment of COVID-19 – A Preliminary Report. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2007764 (2020).   What The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in the New England Journal of Medicine. The preliminary analysis is based […]

Remdesivir for the Treatment of Covid-19 — Final Report


Authors: John H. Beigel, M.D., Kay M. Tomashek, M.D., M.P.H., Lori E. Dodd, Ph.D., Aneesh K. Mehta, M.D., Barry S. Zingman, M.D., Andre C. Kalil, M.D., M.P.H., Elizabeth Hohmann, M.D., Helen Y. Chu, M.D., M.P.H., Annie Luetkemeyer, M.D., Susan Kline, M.D., M.P.H., Diego Lopez de Castilla, M.D., M.P.H., Robert W. Finberg, M.D., et al., for the ACTT-1 Study Group Members* Abstract BACKGROUND Although several therapeutic agents have been […]